Export

EN
FR
Daclatasvir + sofosbuvir
Essential medicine status
General description

INN
Daclatasvir + sofosbuvir
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2021 (TRS 1035) for Chronic hepatitis C
Recommendations
Section
Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations
  • Oral > Solid: 60 mg + 400 mg